Ascendia

  MARKET NEWS

Attralus Announces Enrollment of First Patient in Phase 3 Trial for the Pan-Amyloid Diagnostic 124I-evuzamitide (AT-01) for Cardiac Amyloidosis
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase 2b/3 Data
Abzena Strengthens Board With Appointment of Biopharma Industry Leader, Dr. Moncef Slaoui
Iconovo & Lonza to Collaborate on the Formulation Development of an Intranasal Biologic
Alcami Announces CEO Transition
Vetter Introduces the Next Evolution of the V-OVS Syringe Closure System
Micron Biomedical Wins $2 Million BARDA Competition for its Collaboration With Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
BioMed X Institute Launches New Collaboration With Daiichi Sankyo in Cancer Therapy
PulseSight Therapeutics Announces Initiation of Clinical Plan of Transferrin Vectorized Therapy for Dry AMD/Geographic Atrophy
Pheno Therapeutics Granted Clinical Trial Authorization for Lead Multiple Sclerosis Therapeutic Candidate

  EXPERT CONTENT & RESOURCES

BASF VIDEO - Formulation Design for Tablets and an Introduction to Your New All-in-One Tableting Solution

BASF VIDEO - Formulation Design for Tablets and an Introduction to Your New All-in-One Tableting Solution

In this video, learn what the formulation and parameter targets are to optimize direct compression formulations, and how to accelerate development with BASF’s new all-in-one fit-for-purpose tableting solution.

Who is AbbVie Contract Manufacturing?

Who is AbbVie Contract Manufacturing?

As an embedded CMO, we leverage decades of scientific expertise, operational excellence, and best-in-class facilities to provide you with….

Presentation: Strategies for Amorphous Solid Dispersion Product Development

Presentation: Strategies for Amorphous Solid Dispersion Product Development

In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..

ALBA SUCCESS CASE

Container Selection for a Highly Sensitive Drug Product: A Success Story

For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible.

  FEATURED EDITORIAL

  COMPANY PROFILE

Halo Pharma is a leading provider of pharmaceutical services, including contract dosage form development, commercial manufacturing and analytical services. Our capabilities in the areas of tech transfer, process and pharmaceutical product development, formulation development, production, scale-up and validation, and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. Our expertise across many dosage forms, including complex oral solids, topicals, oral solutions and suspensions and the manufacture of controlled substances is unmatched in North America. Halo Pharma serves a growing global customer base across multiple regulatory environments. These attributes allow Halo Pharma to be a partner of choice for many of today’s large pharma, generic pharma and biotech pharma companies. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations

WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations

In this video, the Lubrizol team together with the IMCD US team takes you through formulation aspects of Carbopol® polymers as well as the results of a case study on an Acetaminophen oral suspension formulation.

WEBINAR - ABISOL Emulsion Preconcentrate Kit & ABISORB-DC Excipient System for Tableting Lipids

WEBINAR - ABISOL Emulsion Preconcentrate Kit & ABISORB-DC Excipient System for Tableting Lipids

ABITEC Technical Business Director, John Tillotson, RPh, PhD, discusses ABITEC’s latest products: The ABISOL Emulsion Preconcentrate kit for the easy formulation of emulsified drug delivery systems and the….

  WHITEPAPERS & WEBINARS

Technical Brief: Mucoadhesive Polymers in Pharmaceutical Formulations

Technical Brief: Mucoadhesive Polymers in Pharmaceutical Formulations

Mucoadhesion Matters

And so does your choice of mucoadhesive polymer.

This technical brief will cover the use of polymers in a variety of dosage forms (buccal/sublingual tablets, liquid, semi-solid formulations, and oral care products) to impart mucoadhesion. The basic mechanism …

CASE STUDY - Overcoming Barriers to Patient Adherence With A Novel Dosage Form

CASE STUDY - Overcoming Barriers to Patient Adherence With A Novel Dosage Form

When a mid-sized pharmaceutical company asked Adare to make a version of their drug that was more convenient for patients with tremors or swallowing difficulties, our experts created a sprinkle formulation of the drug. In this CPHI Award-winning case study, …

WHITEPAPER - Concept to Commercialization: The Role of CDMOs in Driving Innovation Through Phase-Appropriate Technology Transfers

WHITEPAPER - Concept to Commercialization: The Role of CDMOs in Driving Innovation Through Phase-Appropriate Technology Transfers

CDMOs are emerging as critical drivers of innovation within the pharmaceutical and biotech industries. As the pharmaceutical industry continues to evolve, we can expect to see CDMOs play an increasingly important role in drug development and manufacturing. Many companies within …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 22 – Drug Delivery
January 29 – Bioavailability